SARS-CoV-2 Antibody Prevalence in People with and without HIV in Rural Western Kenya, January to March 2020

Abstract

Among 582 participants in Western Kenya who were retrospectively tested from January through March 2020, 19 (3.3%) had detectable SARS-CoV-2 antibodies. The prevalence of detectable SARS-CoV-2 antibodies was similar between participants with and without HIV (3.1% vs. 4.0%, p=0.68). One participant reported a cough in the preceding week but others denied symptoms. These may represent cross-reactivity or asymptomatic infections that predated the first reported COVID-19 cases in Kenya.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Nov 15, 2021
Accession Number
AD1147029

Entities

People

  • Christina S. Polyak
  • Fred Sawe
  • Ibrahim I. Daud
  • John Owuoth
  • Jonah Maswai
  • Julie A. Ake
  • Leigh A. Eller
  • Michelle Imbach
  • Nicole F Dear
  • Trevor A Crowell
  • Valentine Sing'oei

Organizations

  • Walter Reed Army Institute of Research

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Acquired Immune Deficiency Syndrome
  • Africa
  • Biomedical Research
  • Blood
  • Cardiovascular Physiological Phenomena
  • Covid-19
  • Department Of Defense
  • Disease Outbreaks
  • Diseases And Disorders
  • Governments
  • Health
  • Health Services
  • Hiv Infections
  • Hospitals
  • Hygiene
  • Infection
  • Infectious Diseases
  • National Governments
  • Sars
  • United States
  • United States Government
  • Virus Diseases
  • Viruses

Fields of Study

  • Biology

Readers

  • Immunology
  • Mental Health of Military Veterans with Posttraumatic Stress Disorder (PTSD): Risk Factors, Prevalence, Symptoms, and Treatment.
  • Political Violence and Terrorism Studies.